How is metastatic Melanoma different from other stages

Understanding Metastatic Melanoma vs. Earlier Stages

Great question—this distinction is really important because it fundamentally changes how melanoma is treated and what your care team focuses on.

The Key Difference: Where the Cancer Has Spread

Metastatic melanoma (stage 4) means the cancer has spread beyond the skin and regional lymph nodes to distant parts of your body—places like the lungs, liver, brain, or bones. This is different from earlier stages where the cancer is either:

• Confined to the skin (stages 0-2)
• Present in nearby lymph nodes (stage 3)

According to the NCCN Guidelines for Patients: Melanoma, earlier stages are typically treated with surgery as the primary approach. But metastatic melanoma requires a fundamentally different treatment strategy because surgery alone cannot remove cancer that's spread throughout the body.

How Treatment Approaches Differ

Earlier Stages (0-2):

• Surgery to remove the tumor is usually the main treatment
• May include monitoring or observation

Stage 3 (Regional):

• Surgery plus additional treatments like immunotherapy, radiation, or intralesional therapy (T-VEC injections)
• Focus on treating cancer in nearby lymph nodes

Stage 4 (Metastatic): According to NCCN Guidelines, the preferred initial treatment is systemic therapy—meaning drugs that travel through your bloodstream to reach cancer cells throughout your body. These include:

• Immunotherapy (checkpoint inhibitors like pembrolizumab or nivolumab) that help your immune system recognize and attack cancer cells
• Targeted therapy (like dabrafenib/trametinib) if you have a BRAF mutation
• Combination approaches using multiple drugs together
• Surgery, radiation, or intralesional therapy may still be used for specific tumors, but they're not the primary treatment

Why This Matters

The shift from local/regional treatment to systemic treatment reflects an important reality: metastatic cancer requires drugs that can work throughout your entire body, not just in one area. This is why your oncologist's approach changes significantly at stage 4.

Important Questions to Ask Your Care Team

1. What is the extent of my metastatic disease? (Where has it spread? How many sites?)
2. Have I been tested for BRAF mutations or other biomarkers? (This determines which targeted therapies might work)
3. What systemic therapy options are recommended for my specific situation?
4. Will I receive combination therapy, and if so, what are the expected benefits and side effects?
5. Are there clinical trials available that might be appropriate for me?

The Encouraging News

While metastatic melanoma is serious, the American Cancer Society and NCCN Guidelines emphasize that more effective treatments have become available in the past decade. Immunotherapy and targeted therapy have significantly improved outcomes for many patients with stage 4 melanoma, and your care team has multiple evidence-based options to discuss with you.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.